Skip to content
10-K

Annual Report

Instil Bio, Inc. TIL

0001789769-26-000019

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 6.78M sh
Shares Diluted FY 2025 · Dec 31, 2025 6.67M sh
Shares Diluted FY 2025 · Dec 31, 2024 6.51M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$36.62M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$55.7M
Cash And Equivalents FY 2025 · Dec 31, 2025 $6.64M
Cash And Equivalents FY 2025 · Dec 31, 2024 $8.81M
Stockholders Equity FY 2025 · Dec 31, 2025 $113.87M
Stockholders Equity FY 2025 · Dec 31, 2024 $169.44M
Stockholders Equity FY 2025 · Dec 31, 2023 $225.83M
Current Liabilities FY 2025 · Dec 31, 2025 $4.84M
Current Liabilities FY 2025 · Dec 31, 2024 $7.9M
Total Liabilities FY 2025 · Dec 31, 2025 $89.66M
Total Liabilities FY 2025 · Dec 31, 2024 $94.13M
Current Assets FY 2025 · Dec 31, 2025 $191.43M
Current Assets FY 2025 · Dec 31, 2024 $124.47M
Total Assets FY 2025 · Dec 31, 2025 $203.52M
Total Assets FY 2025 · Dec 31, 2024 $263.57M
Eps Diluted FY 2025 · Dec 31, 2025 −$10.70
Eps Diluted FY 2025 · Dec 31, 2024 −$11.39
Eps Basic FY 2025 · Dec 31, 2025 −$10.70
Eps Basic FY 2025 · Dec 31, 2024 −$11.39
Sga Expense FY 2025 · Dec 31, 2025 $27.22M
Sga Expense FY 2025 · Dec 31, 2024 $44.21M
Net Income FY 2025 · Dec 31, 2025 −$71.37M
Net Income FY 2025 · Dec 31, 2024 −$74.14M
Operating Income FY 2025 · Dec 31, 2025 −$78.58M
Operating Income FY 2025 · Dec 31, 2024 −$73.54M